General site disclaimer for phexaloriva.sbs

Important notice

Phexaloriva provides AI-powered recommendations only for consideration.

All information and insights are not intended as specific investment advice.

This page clarifies that all recommendations and insights are general in nature. Phexaloriva is not responsible for personal decision outcomes or losses arising from reliance on automated suggestions. Results may vary from user to user.

General information notice

The content provided is for informational and analytical purposes only. No communication should be viewed as a solicitation or direct recommendation to invest, buy, or sell any asset or instrument. Users remain ultimately responsible for their own choices.

Liability limitations overview

Phexaloriva does not guarantee accuracy or suitability, and cannot be held responsible for losses.

Technical delays or interruptions in the availability of the recommendation platform.
Inadvertent errors in data delivery or algorithmic output.
Outcomes resulting from independent financial actions taken by users.
Losses due to third-party links or unaffiliated resources mentioned on the site.

Content accuracy statement

While we make reasonable efforts to ensure accuracy, some data may be incomplete, outdated, or contain errors. The user is urged to verify any essential information through independent means before making decisions based on it.

No warranty is given for content completeness or effectiveness.

No professional advice warning

Materials provided do not substitute for consultations with licensed advisors or legal, tax, or medical professionals. Seek specialist advice before acting.

External links and partners

Phexaloriva is not responsible for the reliability or security of third-party content linked from the website.

No results guarantee or prediction notice

We do not promise any specific trading result or financial outcome. Results may differ and past performance does not predict future returns.

User experience variation advisory

Your experience and results using Phexaloriva’s services may vary compared to others, depending on individual actions and market circumstances.

Financial content and regulatory notice

This is not a solicitation for financial products, nor an invitation to pursue financial arrangements through phexaloriva.sbs.

Phexaloriva does not offer, promote, or sell any financial instruments, management, or education.
No fees, rates, or investment-related returns are published or guaranteed.
No structured consulting or training services are included in the offering.

South African jurisdiction statement

Platform terms align with national regulations governing the financial sector.

Jurisdiction for legal purposes and any platform disputes lies within the Republic of South Africa.

South African law governs all content and operations.

Services are delivered in accordance with country-specific legislation and related compliance standards.

Indemnification

You agree to hold phexaloriva.sbs harmless from third-party claims or liabilities arising from misuse.

Severability

If any disclaimer term is invalid or unenforceable, the rest remain effective.

Modifications

We may update this disclaimer as needed. Updates take effect once published online.

Contact us

Please direct compliance or disclaimer questions to our listed contacts below.

Email address: content@phexaloriva.sbs

Phone number: +27331887393

Physical address: Pharos House, 18 The Boulevard, Westville, Durban 3629 South Africa

Effective date: 20 December 2025

Last updated: 20 December 2025